The proposal, entitled augmenting the quality and duration of the immune response with a novel TLR2 agonist-aluminum combination adjuvant, was submitted by teichos laboratories, LLC, west lafayette,…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00057
- Awardee
-
Teichos Laboratories, LLC UEI UGFLPLUM9UP5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46231, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $300,000 |
About this award
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to Teichos Laboratories, LLC, a small business located in West Lafayette, IN. The $300,000 firm fixed price contract is for research on a novel TLR2 agonist-aluminum combination adjuvant to improve the quality and duration of the immune response. This SBIR contract was awarded under a solicitation that sought innovative research proposals from small businesses to address NIH and Centers for Disease Control and Prevention (CDC) mission needs across topics like infectious diseases, cancer, heart/lung health, and emerging pathogens. The contract is set aside for total small business participation.
Description
The proposal, entitled augmenting the quality and duration of the immune response with a novel TLR2 agonist-aluminum combination adjuvant, was submitted by teichos laboratories, LLC, west lafayette, in, with DR. Larry chris blaszczak as the PI. The O
Quick answers
Who was awarded contract 75N93021C00057?
75N93021C00057 was awarded to Teichos Laboratories, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2021.
How much is contract 75N93021C00057 worth?
The government has obligated $300,000 on 75N93021C00057.
Was contract 75N93021C00057 competed?
The extent of competition for 75N93021C00057 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award